Shares rebound at scent of draft sequence

Paul Smaglik

Nature, 2000, vol. 405, issue 6789, 875-875

Abstract: Washington Shares in genomics companies have been rising steadily in anticipation of the imminent completion of the draft human genome sequence.

Date: 2000
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/35016228 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:405:y:2000:i:6789:d:10.1038_35016228

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35016228

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().